Creative Planning’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-28,735
Closed -$2.3M 5138
2016
Q4
$2.3M Sell
28,735
-2,153
-7% -$171K 0.01% 364
2016
Q3
$2.46M Buy
30,888
+1,470
+5% +$119K 0.02% 332
2016
Q2
$2.29M Buy
29,418
+3,358
+13% +$239K 0.02% 306
2016
Q1
$1.43M Sell
26,060
-190
-0.7% -$10.4K 0.01% 398
2015
Q4
$1.62M Buy
26,250
+772
+3% +$48.7K 0.01% 359
2015
Q3
$1.61M Sell
25,478
-587
-2% -$41.9K 0.01% 346
2015
Q2
$1.91M Buy
26,065
+1,954
+8% +$141K 0.02% 299
2015
Q1
$1.58M Buy
24,111
+73
+0.3% +$4.85K 0.01% 335
2014
Q4
$1.56M Buy
24,038
+2,328
+11% +$150K 0.02% 331
2014
Q3
$1.3M Buy
21,710
+2,055
+10% +$134K 0.02% 332
2014
Q2
$1.36M Buy
19,655
+701
+4% +$45.4K 0.02% 309
2014
Q1
$1.24M Buy
18,954
+3,191
+20% +$208K 0.02% 311
2013
Q4
$977K Buy
15,763
+86
+0.5% +$4.98K 0.02% 309
2013
Q3
$841K Buy
15,677
+2,548
+19% +$131K 0.02% 306
2013
Q2
$599K Buy
+13,129
New +$569K 0.01% 360

Other funds holding STJ

Creative Planning's STJ Position: Q1 2017 in Review

Creative Planning sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 28,735 shares — an estimated $2.3M sold.

Creative Planning first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.46M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Creative Planning reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Creative Planning sold 28,735 St Jude Medical shares in Q1 2017, an estimated $2.3M.
  • Creative Planning first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Creative Planning's St Jude Medical position peaked at $2.46M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Creative Planning's 13F filing for Q1 2017, filed 7 Apr 2017.